SCHEMBL26469152

SCHEMBL26469152

CC(C)CNC(=O)c1cnc(Br)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HTT P42858 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 5/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SLC8A1 P32418 1/20 0.39
FPR3 P25089 2/20 0.39
FPR2 P25090 2/20 0.39
MLYCD O95822 1/20 0.39
NAMPT P43490 1/20 0.39
POLB P06746 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12448122 0.84 HCAR2 (0.51) ALDH1A1RAB9ASMN1; SMN2GAAKMT2A
SCHEMBL12449167 0.84 GAA (0.42) ALDH1A1RAB9ANPC1SMN1; SMN2GAA
SCHEMBL11648634 0.81 GAA (0.47) GAAKDM4ENPSR1NAMPT
SCHEMBL11648917 0.78 ALDH1A1 (0.44) ALDH1A1RAB9ANPC1SMN1; SMN2HTT
SCHEMBL11658564 0.77 NAMPT (0.42) RAB9AGAAKMT2AKDM4ENPSR1
SCHEMBL11652256 0.76 RECQL (0.46) ALDH1A1RAB9ANPC1SMN1; SMN2GAA
SCHEMBL11656613 0.76 GAA (0.41) GAAKDM4ENPSR1NAMPT
SCHEMBL23562689 0.75 ALDH1A1 (0.48) ALDH1A1RAB9ANPC1SMN1; SMN2GAA
SCHEMBL11650054 0.75 USP2 (0.46) ALDH1A1RAB9ANPC1SMN1; SMN2HSD17B10
SCHEMBL11649748 0.75 NAMPT (0.40) ALDH1A1RAB9AGAAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641857-B2 Unusually potent ABA receptor pan-antagonists THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641857-B2 Unusually potent ABA receptor pan-antagonists AAK1, ATP5PO, BROX ALDH1A1 4006/4885RAB9A 2150/4885NPC1 4007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.